The landscape of eye disease management is rapidly evolving, driven by groundbreaking technological advancements. As eye diseases become increasingly prevalent, particularly among ageing populations, innovative solutions are crucial for enhancing diagnosis, treatment, and patient outcomes. This blog delves into the pressing need for these advancements, explores the transformative power of AI retinal imaging, and highlights how Optain Health is leading the way in revolutionising eye care.

The Growing Need for Innovation in Eye Disease Management

Globally, an estimated 2.2 million Australians experience moderate to severe vision loss (Australian Institute of Health and Welfare – Eye Health). This staggering statistic underscores the urgent need for effective eye disease management. Delayed diagnosis and treatment can lead to irreversible vision loss and substantial healthcare costs.

Over 13 million people in Australia are affected by one or more chronic eye conditions. As the population ages, this number is expected to rise significantly, emphasising the necessity for innovations in eye care. The economic burden of delayed diagnosis is substantial, impacting both healthcare systems and individuals’ quality of life.

Advancements in technology and research are driving progress in ophthalmology. Cutting-edge solutions enable earlier detection, offer improved treatment options, and enhance patient outcomes. With nearly 1 in 6 Australians experiencing some form of vision impairment, including conditions like diabetic retinopathy, glaucoma, and age-related macular degeneration, there is a pressing demand for advanced technologies in eye disease management.

How AI is Transforming Eye Disease Diagnosis and Treatment

AI is revolutionising ophthalmology, particularly in the diagnosis and treatment of eye diseases. AI-powered retinal imaging tools, such as those offered by Optain Health, capture high-resolution images of the retina, providing a detailed view of its structure and blood vessels. AI algorithms then analyse these images, which can identify subtle abnormalities that may indicate early signs of disease.

Benefits of AI in Eye Care:

• Earlier Detection: AI can pinpoint potential issues at their earliest stages, allowing prompt intervention and improved treatment outcomes.
• Enhanced Accuracy: AI algorithms analyse vast amounts of data with exceptional precision, reducing the risk of human error.
• Streamlined Workflows: AI tools automate repetitive tasks, freeing up valuable time for clinicians to focus on patient care.

AI is transforming eye care by enabling faster and more accurate diagnoses of conditions such as diabetic retinopathy, age-related macular degeneration, and glaucoma. Unlike traditional methods, which often rely on subjective assessments, AI retinal imaging provides precise, objective data. This allows for earlier intervention and potentially better outcomes, significantly improving the management of eye diseases and reducing the risk of severe vision loss and associated complications.

Optain Health’s Role in Advancing Eye Disease Management

Optain Health is a leading innovator in the eye care industry, dedicated to developing and providing solutions that empower clinicians and enhance patient care. Our advanced retinal imaging technologies, including the Eyetelligence Assure and Resolve Camera, offer a non-invasive and efficient method for capturing high-quality retinal images.

Optain’s AI-powered solutions enable clinicians to:

• Detect a broader range of eye diseases at earlier stages.
• Monitor disease progression more effectively.
• Develop personalised treatment plans for optimal patient outcomes.

Optain is at the forefront of integrating cutting-edge research with practical clinical tools to enhance eye health management. By leveraging machine learning algorithms, Optain’s technology can analyse retinal images with unprecedented speed and accuracy, facilitating the early detection of disease and enabling more timely interventions.

Optain Health’s state-of-the-art solutions set new standards for non-invasive eye care technology and lead the charge in eye disease screening. Our AI retinal screening tools, including the Eyetelligence Assure and Resolve Camera, integrate advanced imaging with AI, empowering clinicians to detect and manage eye diseases earlier. This improves patient care and helps reduce long-term costs, showcasing Optain Health’s commitment to advancing eye disease management and overall eye health.

Non-Invasive Retinal Screening: A Game Changer for Clinicians

Traditional methods of diagnosing eye diseases can be time-consuming and invasive. Non-invasive retinal screening, as facilitated by Optain’s technology, offers a transformative solution for clinicians.

Benefits of Non-Invasive Screening:

• Improved Patient Comfort: Eliminates the need for uncomfortable procedures or dilation drops.
• Enhanced Patient Compliance: Greater comfort encourages regular eye exams.
• Faster Diagnostic Workflow: Enables clinicians to see more patients and provide timely diagnosis.

Non-invasive eye care technology is revolutionising eye disease management. Optain’s retinal screening solutions offer a painless, quick, and effective method for assessing eye health. This technology supports frequent monitoring, which is crucial for managing progressive conditions. The non-invasive nature of these Optain Health solutions allows for comprehensive health assessments without pupil dilation or discomfort.

Non-invasive technologies have significantly improved eye disease treatment by providing patients a safer, more comfortable experience. Optain Health’s tools, like the Eyetelligence Assure, enable detailed examinations without invasive procedures. This results in accurate, timely diagnosis essential for effective disease management and allows clinicians to deliver better care with increased efficiency.

The Future of Eye Health: Emerging Technologies and Trends

The future of eye health is brimming with exciting possibilities. Beyond AI and non-invasive screening, several promising technologies are on the horizon:

• Gene Editing: Therapies that hold the potential to cure inherited eye diseases.
• Telemedicine: Platforms that improve access to eye care, especially in remote areas.
• Personalised Medicine: Advancements in genomics paving the way for individualised treatment plans.

Emerging Technologies:

• Adaptive Optics: Enhancing the resolution of retinal imaging to unprecedented levels.
• Gene Therapy and Stem Cell Treatments: Showing promise for previously untreatable conditions.
• AI-Integrated Wearables: Enabling continuous monitoring and early intervention.

These technologies are setting new benchmarks in eye health management, promising significant improvements in diagnosis and treatment. As we look to the future, it’s clear that innovations in eye disease management will continue to play a crucial role in preserving vision and improving quality of life for millions. With Optain Health leading the charge, we can expect even more groundbreaking advancements in the years to come. Contact us for more information on how Optain is revolutionising eye health management.

FAQs

What are the latest innovations in eye disease management?

The latest innovations in eye disease management include AI-powered retinal screening, adaptive optics for high-resolution imaging, gene therapy, and stem cell treatments. These technologies are enhancing how eye diseases are diagnosed and treated, offering non-invasive, accurate assessments that improve patient care.

How is AI being used to improve the diagnosis and treatment of eye diseases?

AI is transforming eye care by analysing high-resolution retinal images to detect early signs of conditions like diabetic retinopathy and age-related macular degeneration. AI’s ability to process and interpret vast amounts of data provides precise diagnoses and enables personalised treatment plans.

How does Optain Health’s retinal screening technology aid in early detection?

Optain Health’s retinal screening technology, including the Eyetelligence Assure and Resolve Camera, captures high-resolution images of the retina and uses AI to analyse them. This process detects subtle abnormalities early, allowing for timely intervention and improved patient outcomes.

What are the benefits of non-invasive technologies in managing eye diseases?

Non-invasive technologies, such as Optain Health’s retinal imaging solutions, offer:

• Enhanced Patient Comfort: Avoids uncomfortable procedures and dilation drops.
• Increased Compliance: Greater comfort encourages regular eye exams.
• Faster Diagnostic Workflow: Enables quicker diagnoses and higher patient throughput.

What future technologies are emerging in eye health care?

Future technologies in eye health care include:

• Gene Editing: Potential to cure inherited eye diseases.
• Telemedicine: Expanding access to eye care, especially in remote areas.
• Personalised Medicine: Customising treatments based on individual genetic profiles.
• Adaptive Optics: Improving imaging resolution for detailed retinal assessments.
• AI-Integrated Wearables: Providing continuous monitoring and early intervention.

Disclaimer: The information provided in this blog is for general informational purposes only and is not intended as medical advice. Consult with a healthcare provider for personalised advice tailored to your needs. Obtain Health does not assume any liability for actions taken based on this information.

Discover how early detection of eye diseases using advanced AI retinal imaging can prevent serious vision loss, improve patient outcomes, and reduce long-term healthcare costs.

Your eyes are your gateway to the world, and protecting them starts with early detection. From diabetic retinopathy to glaucoma and age-related macular degeneration, many serious eye diseases develop without early warning signs. But with regular eye exams and cutting-edge tools like AI retinal screening, you can take control and spot potential issues before they affect your vision.

Acting early can preserve your sight, improve your quality of life, and prevent serious long-term complications. Read on to discover how staying vigilant about your eye health can make all the difference.

The Importance of Early Detection in Eye Health

Vision impairment affects millions of Australians. According to the Australian Bureau of Statistics (ABS) 2017–18 National Health Survey (NHS), an estimated 13 million people have one or more chronic eye conditions. The Australian Institute of Health and Welfare anticipates this number will rise as the population ages.

The good news? Many eye conditions, such as diabetic retinopathy, glaucoma, and age-related macular degeneration (AMD), can be effectively managed or even prevented with early diagnosis and timely treatment. Research shows that up to 95% of blindness caused by diabetic retinopathy can be prevented through early diagnosis and treatment. Additionally, Australia’s Eye Health Survey 2016, cited in this article, highlights that regular screening can prevent up to 90% of diabetes-related vision loss.

Early detection allows for intervention before symptoms appear, significantly improving treatment outcomes and reducing the likelihood of permanent damage. It also helps prevent complications linked to certain eye diseases, such as an increased risk of cardiovascular disease associated with diabetic retinopathy. This early diagnosis can bring a sense of relief, knowing that you’re taking proactive steps to protect your vision. 

By identifying early signs of glaucoma or conducting regular diabetic retinopathy screenings, you can avoid irreversible damage that might otherwise go unnoticed until it’s too late. These regular screenings can provide a sense of security, knowing that you’re staying ahead of potential issues.

Common Eye Diseases and Their Early Signs

Several eye conditions can significantly impact vision. Recognising their early signs can be crucial for managing or even preventing severe vision loss. Here are some critical conditions to watch for:

• Diabetic Retinopathy: A complication of diabetes affecting the blood vessels in the retina. Early signs include:
  • Blurry vision, especially at night
  • Floaters or flashes of light
• Glaucoma: Known as the “silent thief of sight,” it involves increased pressure within the eye that damages the optic nerve. Early symptoms may include:
  • Peripheral vision loss
  • Headaches
• Age-Related Macular Degeneration (AMD): Affects the macula, responsible for central vision. Early signs include:
  • Difficulty reading or seeing fine details
  • Distorted vision (where straight lines appear wavy)

It’s crucial to remember that the absence of symptoms does not necessarily mean good eye health. Regular comprehensive eye exams are essential for everyone, regardless of age or perceived vision quality. Early detection of these diseases can prevent permanent vision loss and reduce the need for more invasive treatments in the future.

For a thorough health assessment, consider using advanced screening tools like those offered by Optain Health or visiting an optometrist for a comprehensive evaluation.

How AI Technology Is Revolutionising Eye Disease Detection

The field of eye care is undergoing a remarkable transformation with the integration of Artificial Intelligence (AI). AI retinal screening tools, such as those offered by Optain, are at the forefront of this revolution, dramatically changing how eye diseases are detected and managed.

These cutting-edge technologies capture high-resolution images of the retina, providing a detailed view of its structure and blood vessels. AI algorithms then analyse these images, identifying subtle abnormalities that might indicate early signs of eye diseases.

Traditionally, eye conditions were diagnosed based on physical symptoms or after advanced-stage disease had developed. Today, AI-powered tools like AI retinal imaging are redefining this approach. By employing sophisticated algorithms to examine retinal images, AI can detect early indicators of diseases such as AMD or diabetic retinopathy before symptoms are noticeable.

This advancement allows for:

• Early diagnosis
• More personalised treatment plans
• Enhanced accuracy
• Non-invasive procedures

AI technology improves patient outcomes and reduces long-term healthcare costs by facilitating early intervention and preventing disease progression. The shift to AI-driven diagnostics represents a significant leap forward in eye care, making it more efficient and effective than ever before.

Optain Health’s Role in Early Detection: Advanced Retinal Imaging

At Optain Health, we are transforming eye care with our state-of-the-art technology. Our innovative solutions, including the Eyetelligence Assure and Resolve Camera, empower clinicians to offer fast, accurate, and non-invasive methods for retinal screening. Discover how we advance early detection and provide comprehensive health assessment tools.

Our advanced tools support eye care professionals in identifying potential issues at their earliest stages, facilitating prompt intervention and significantly enhancing patient outcomes. Incorporating our AI-driven technology into routine screenings ensures that patients receive precise and timely assessments.

What makes our retinal imaging technology exceptional includes the following:

• The speed with which we deliver results
• The accuracy we achieve in detecting early signs of disease
• The non-invasive nature of our methods ensures a comfortable experience for patients

With our cutting-edge technology, you can trust that you are receiving the highest standard of care. Contact us to schedule an assessment or learn more about how our technology can benefit your eye health.

Improving Patient Outcomes Through Early Diagnosis

The advantages of early detection of eye diseases extend well beyond preserving vision. Early diagnosis can lead to:

• More Effective Treatment Options: Detecting conditions like diabetic retinopathy, glaucoma, or AMD early often results in better treatment outcomes, reducing the risk of vision loss and long-term complications.
• Reduced Healthcare Costs: Addressing eye diseases early can significantly lower the overall costs associated with managing chronic conditions. Timely intervention often means fewer expensive and invasive treatments later on.
• Improved Quality of Life: Maintaining healthy vision is crucial for preserving independence and well-being. Early diagnosis helps ensure that patients can continue to enjoy an active, fulfilling life without the limitations caused by vision impairment.

By prioritising early detection of disease, we can empower individuals to protect their vision and improve their quality of life. Studies have demonstrated that early intervention not only slows the progression of eye diseases but also helps manage related health conditions. For instance, vision impairment is frequently associated with chronic diseases such as cardiovascular issues and diabetes.

Leveraging advanced technologies like AI retinal imaging enhances our ability to catch eye diseases early, offering patients the opportunity for reduced healthcare costs, better daily functioning, and improved health outcomes.

FAQ

Why is early detection important for eye diseases?

Early detection is vital because it enables timely intervention, often before symptoms appear. This approach can significantly enhance treatment outcomes, reduce the risk of permanent vision loss, and prevent complications related to eye diseases, such as an increased risk of cardiovascular issues. Many eye diseases progress without noticeable symptoms, making early diagnosis essential for preserving vision.

What are the common early signs of serious eye conditions?

Early signs of serious eye conditions can include:

• Blurry vision, especially at night
• Seeing floaters or flashes of light
• Peripheral vision loss
• Difficulty reading or seeing fine details
• Distorted vision (e.g., straight lines appearing wavy)

Specifically, symptoms of conditions like diabetic retinopathy may include blurred vision and dark spots. Glaucoma might involve pressure buildup and potential optic nerve damage. At the same time, AMD often presents with central vision distortion.

How does AI technology assist in the early detection of eye diseases?

AI technology enhances early detection through advanced retinal imaging tools that analyse high-resolution images of the retina. These AI-powered systems identify subtle abnormalities that may indicate early signs of diseases like diabetic retinopathy and AMD. This technology allows for faster, more accurate, and non-invasive screening.

How can Optain Health’s retinal screening technology help improve diagnosis?

Optain Health’s retinal imaging technology, including tools like the Eyetelligence Assure and Resolve Camera, provides clinicians with advanced capabilities for capturing and analysing detailed retinal images. This enables earlier and more precise detection of eye diseases, leading to better treatment outcomes and improved patient care.

What are the long-term benefits of detecting eye diseases early?

Early detection of eye diseases offers numerous long-term benefits:

• More Effective Treatment Options: Timely intervention results in better treatment and minimises vision loss.
• Reduced Healthcare Costs: Early treatment can lower the overall cost of managing chronic eye conditions.
• Improved Quality of Life: Maintaining healthy vision helps preserve independence and overall well-being.
• Prevention of Long-Term Complications: Early diagnosis can prevent severe vision loss and manage related health conditions.

Disclaimer: The information provided in this blog is for general informational purposes only and is not intended as medical advice. For personalised advice tailored to your individual needs, consult with a healthcare provider. Optain Health does not assume any liability for actions taken based on this information.

Introduction to AI in Healthcare

Artificial Intelligence (AI) is rapidly growing as a transformative force in healthcare, offering unprecedented opportunities to enhance diagnostic accuracy, streamline clinical workflows, and improve patient outcomes. In particular, AI is playing a pivotal role in revolutionising how we detect, monitor, and manage various ocular conditions. 

By leveraging the power of machine learning and advanced algorithms, AI-enabled screening is setting new standards in eye health, offering a new level of precision and accessibility.

The Importance of Early Detection in Eye Health

Early detection of eye diseases is crucial in preventing severe vision impairment and blindness. Conditions such as diabetic retinopathy, age-related macular degeneration, and glaucoma can lead to irreversible vision loss if not detected and treated in their early stages. Traditionally, the detection of these conditions has relied heavily on manual examination and interpretation by ophthalmologists, which can be time-consuming and subject to human error.

AI-enabled screening changes this paradigm by providing automated, highly accurate analysis of retinal images. This technology can detect even the slightest abnormalities in the retina, allowing for earlier intervention and treatment. By catching these conditions early, AI not only helps preserve vision but also improves patients’ quality of life and reduces the overall burden on healthcare systems.

How Optain Health’s AI-Enabled Technology is Setting New Standards

Optain Health is at the forefront of this revolution, offering cutting-edge AI-enabled technology that is setting new standards in eye health screening. Our Eyetelligence Assure and Assure+ systems represent a significant leap forward in the detection and management of ocular conditions. This advanced AI-driven platform is designed to analyse retinal images with unparalleled accuracy, identifying early signs of disease that might be missed by traditional methods.

Eyetelligence Assure is not just a tool for specialists; it’s a solution that can be integrated into a variety of healthcare settings, including general practice. This broad applicability ensures that more patients have access to early detection and timely treatment, regardless of their location or access to specialised eye care.

Real-World Applications of AI in Eye Health

The real-world applications of AI in eye health are both vast and impactful. One of the most significant areas is in the management of diabetic retinopathy, a leading cause of blindness among working-age adults. AI-powered screening tools can analyse retinal images for signs of diabetic retinopathy with a high degree of accuracy, enabling earlier diagnosis and treatment. This is particularly important in primary care settings, where patients may not have immediate access to an ophthalmologist.

Another critical application is in the early detection of glaucoma, a condition often referred to as the “silent thief of sight” because it typically presents no symptoms until significant vision loss has occurred. AI algorithms can detect subtle changes in the optic nerve head and retinal nerve fibre layer, which are early indicators of glaucoma. By identifying these changes early, AI helps prevent the progression of the disease and preserves vision.

Age-related macular degeneration (AMD) is another area where AI is making a significant impact. AI-enabled tools can detect the early signs of AMD, such as drusen deposits or retinal pigment abnormalities, allowing for prompt intervention and management. This is particularly beneficial for older adults, who are at higher risk of developing AMD and may not seek regular eye care.

Bridging the Gap in Eye Care Accessibility

One of the most exciting benefits of AI in eye health is its potential to bridge the gap in care accessibility, particularly in underserved communities. In many parts of the world, access to specialised eye care is limited, leading to delayed diagnosis and treatment of preventable conditions. AI-enabled screening tools can be deployed in primary care settings, community health centres, and even via telemedicine platforms, bringing high-quality eye care to those who need it most.

For example, in rural or remote areas where access to ophthalmologists is scarce, AI-powered retinal screening can be performed by general practitioners or trained technicians. The results can then be reviewed by specialists remotely, ensuring that patients receive timely and accurate diagnoses without the need to travel long distances. This not only improves access to care but also reduces the overall cost and burden on healthcare systems.

Future Prospects and Innovations

The future of AI in eye health is incredibly promising, with ongoing research and development focused on expanding its capabilities and applications. As AI technology continues to evolve, we can expect even more sophisticated algorithms that can detect a broader range of ocular conditions with greater accuracy. These advancements will further enhance the ability of AI to identify early signs of diseases, enabling more personalised and effective treatment plans.

The integration of AI with other emerging technologies, such as wearable devices and IoT (Internet of Things), holds the potential to revolutionise how we monitor and manage eye health. Wearable devices equipped with AI algorithms could provide continuous monitoring of eye health, alerting patients and healthcare providers to any changes that may require intervention. This proactive approach to eye care could significantly reduce the incidence of severe vision impairment and blindness.

To learn more about Optain Health’s mission and see how you can benefit from our cutting-edge technology, contact us today.

FAQs

How does AI-enabled screening improve early detection of eye diseases?

AI-enabled screening improves early detection by providing highly accurate, automated analysis of retinal images. This technology can detect even the slightest abnormalities in the retina, enabling earlier diagnosis and treatment of conditions like diabetic retinopathy, glaucoma, and AMD.

What are the benefits of using AI technology for eye health?

The benefits of using AI technology for eye health include enhanced diagnostic accuracy, faster analysis, and the ability to detect diseases at an earlier stage. AI also makes eye health screening more accessible, particularly in underserved areas, and reduces the burden on healthcare systems.

How does Optain Health’s AI technology work?

Optain Health’s AI technology, including the Eyetelligence Assure system, works by analysing retinal images to detect early signs of eye diseases. The AI algorithms are trained on vast datasets, allowing them to identify complex patterns and anomalies that may indicate the presence of conditions such as diabetic retinopathy, glaucoma, and AMD.

Can AI screening tools be used by general practitioners?

Yes, AI screening tools can be used by general practitioners, particularly in primary care settings. These tools are designed to be user-friendly and can provide real-time analysis of retinal images, allowing GPs to detect early signs of eye diseases and refer patients for further evaluation if necessary.

What makes AI better than traditional eye screening methods?

AI offers several advantages over traditional eye screening methods, including greater accuracy, faster analysis, and the ability to detect early-stage diseases that might be missed by manual examination. Further, AI-enabled tools can be more widely deployed, making eye health screening more accessible to a larger population.

Artificial Intelligence (AI) is revolutionising the healthcare landscape, offering innovative solutions that enhance diagnostic accuracy, streamline operations, and improve patient outcomes. In recent years, AI’s integration into healthcare has accelerated, driven by its ability to analyse vast amounts of data quickly and accurately. From imaging to predictive analytics, AI is transforming how medical professionals diagnose and treat diseases. 

One of the most promising areas of AI application is in the field of eye health, where it aids in screening for cardiovascular diseases (CVDs). By leveraging the power of AI, healthcare providers can now harness retinal imaging to gain insights into cardiovascular health, thereby paving the way for early detection and intervention.

The Intersection of Eye Health and Cardiovascular Screening

The eye is often described as the window to the body, and advancements in medical technology are making this statement truer than ever. Retinal imaging has become a critical tool in detecting various health conditions, including cardiovascular diseases. The intricate network of blood vessels in the retina reflects the health of the vascular system throughout the body. Changes or abnormalities in these vessels can indicate the presence of cardiovascular issues, such as hypertension or atherosclerosis.

Traditionally, cardiovascular screening relied on a combination of lifestyle assessments, blood tests, and imaging studies like echocardiograms or MRIs. However, these methods can be invasive, expensive, and not always accessible to everyone. Retinal imaging, in contrast, offers a non-invasive, cost-effective alternative that can be easily performed in an outpatient setting. By analysing retinal images, healthcare providers can detect early signs of cardiovascular problems, enabling timely intervention and management.

How AI Enhances Cardiovascular Screening Through Eye Health

AI has emerged as a powerful ally in enhancing the accuracy and efficiency of cardiovascular screening through eye health. The integration of AI algorithms with retinal imaging allows for the automatic detection of subtle changes and patterns that may be indicative of cardiovascular diseases. These algorithms are trained on vast datasets, enabling them to recognise complex patterns and anomalies that might be missed by the human eye. The World Health Organisation has emphasised that AI could play a transformative role in diagnosing and treating health issues. 

One of the significant advantages of AI in this context is its ability to process and analyse large volumes of data quickly. This capability not only speeds up the diagnostic process but also improves accuracy. AI can identify risk factors and predict cardiovascular events by analysing retinal images, enabling healthcare providers to make informed decisions about patient care.

Moreover, AI-driven tools can be integrated into telemedicine platforms, making cardiovascular screening more accessible to patients in remote or underserved areas. By providing real-time analysis of retinal images, AI can facilitate early diagnosis and intervention, reducing the risk of severe cardiovascular events and improving overall patient outcomes.

The Eyetelligence System

Optain Health’s Eyetelligence Assure+ is a pioneering AI system designed to enhance the screening process for cardiovascular diseases through eye health diagnostics. This advanced tool analyses retinal images to detect subtle signs of vascular health issues, providing healthcare professionals with critical insights into a patient’s cardiovascular risk profile. 

Eyetelligence Assure+ not only improves diagnostic accuracy but also enables early intervention, offering a proactive approach to managing heart health. The system’s integration with telemedicine platforms extends its reach, ensuring that even remote or underserved populations can benefit from cutting-edge cardiovascular screening. The Eyetelligence Assure+ boasts a 95% accuracy rate and conforms to the performance and safety standards of over 30 countries across the EU and Australasia. 

Future Prospects and Innovations

The future of AI in cardiovascular screening through eye health holds immense promise, with ongoing research and development focused on expanding its capabilities and applications. As AI technology continues to evolve, several exciting prospects and innovations are on the horizon.

AI-powered devices are becoming more portable and user-friendly, making them accessible to a broader range of healthcare providers. These devices could be used in primary care settings, pharmacies, and even at home, enabling individuals to monitor their cardiovascular health regularly. By empowering patients with tools for self-assessment, AI can promote proactive healthcare management and reduce the burden on healthcare systems.

Furthermore, the integration of AI with other emerging technologies, such as wearable devices, advanced cameras and the IoT (Internet of Things), is expected to enhance cardiovascular monitoring and management. Wearable devices equipped with AI algorithms can continuously track vital signs and provide real-time feedback, alerting individuals and healthcare providers to potential cardiovascular issues before they escalate.

As AI continues to advance, ethical considerations and regulatory frameworks will play a crucial role in ensuring its safe and effective implementation in healthcare. Collaborations between researchers, healthcare providers, and policymakers will be essential to address privacy concerns, ensure data security, and establish guidelines for AI usage in clinical practice.

The integration of AI in cardiovascular screening through eye health represents a significant leap forward in preventive healthcare. By harnessing the power of AI, healthcare providers can detect cardiovascular diseases early, improve patient outcomes, and ultimately save lives. As technology continues to evolve, the potential for AI to transform healthcare and empower individuals to take control of their health is boundless.

FAQs

How does AI contribute to advancements in cardiovascular screening?

AI enhances cardiovascular screening by analysing retinal images for early signs of cardiovascular diseases. It detects subtle patterns and anomalies that may indicate issues like hypertension or atherosclerosis, allowing for timely intervention and improved patient outcomes.

What is the connection between eye health and cardiovascular diseases?

The retina’s blood vessels mirror the vascular system’s health throughout the body. Changes in these vessels can signal cardiovascular issues, making retinal imaging a valuable tool for screening conditions such as hypertension and atherosclerosis.

How is AI used in eye health diagnostics?

AI is used in eye health diagnostics to analyse retinal images, detecting abnormalities that indicate eye diseases or systemic conditions like cardiovascular diseases. AI algorithms quickly process large data sets, improving diagnostic accuracy and efficiency.

What future developments are expected in AI and cardiovascular screening?

Future developments include more accurate AI algorithms for detecting a broader range of cardiovascular conditions, portable AI-powered devices for regular monitoring, and the integration of AI with wearable technology for continuous health tracking. These advancements promise to improve early diagnosis and personalised care.

Glaucoma is a leading cause of blindness worldwide, affecting over 60 million people and is predicted to increase by over 50% over the next 20 years. Early detection and treatment are crucial in preventing vision loss. In eye health, advancements in artificial intelligence (AI) are heralding a new era of precision and accessibility in glaucoma screening. By harnessing the power of AI, healthcare providers like Optain Health can now detect subtle signs of this silent thief of sight with unprecedented accuracy and efficiency.

Introduction to Glaucoma and Its Global Impact

Glaucoma is a group of eye conditions that damage the optic nerve, often caused by abnormally high pressure in the eye. It is a significant cause of blindness globally, affecting over 60 million people. Early detection through regular screenings is vital to manage and treat glaucoma effectively. However, traditional screening methods can be time-consuming and may miss early signs of the disease.

The Role of Artificial Intelligence in Glaucoma Detection

AI technologies, particularly machine learning models, are transforming glaucoma detection. These models, while powerful, are only as effective as the data they are trained on. This is where the role of healthcare professionals becomes crucial. By providing accurate and comprehensive eye scan data, healthcare professionals are instrumental in training these AI algorithms to identify patterns and signs of glaucoma that may be missed by human eyes.

AI technologies, particularly machine learning models, are transforming glaucoma detection. These models analyse eye scan data to predict risk levels and enhance understanding of optical health. AI algorithms can process vast amounts of data quickly, identifying patterns and signs of glaucoma that may be missed by human eyes.

Comparing Traditional vs. AI-Assisted Glaucoma Screening Methods

Traditional glaucoma screening methods, such as visual field tests and optical coherence tomography (OCT), require specialised equipment and trained professionals. In contrast, AI-assisted techniques offered by Optain Health’s Eyetelligence Assure Suite have several advantages:

• Speed: AI can analyse eye scans in seconds, providing immediate results.
• Accuracy: AI models have shown high accuracy in detecting early signs of glaucoma, reducing false negatives and positives.
• Cost-Effectiveness: AI technology can lower the cost of screenings by automating the process and reducing the need for extensive human resources.

Case Studies: Success Stories in AI and Eye Health

AI technologies have proven their efficacy in transforming glaucoma detection, particularly in enhancing early detection. As evidenced by substantial research and real-world applications, Optain Health’s AI tools and others like it have been instrumental in this. In a study highlighted in the Journal of Ophthalmology (PMC7571273), AI algorithms were used to rapidly and accurately analyse complex eye scan data. The results were remarkable: AI not only improved the detection rates of early-stage glaucomatous changes but also significantly reduced the time required for diagnosis by around 50%. This efficiency led to timely interventions and improved patient outcomes, demonstrating AI’s potential to revolutionise traditional screening methods.

Optain Health’s Eyetelligence Assure Suite AI tools have reported impressive outcomes, demonstrating accuracy rates exceeding 95% in identifying early signs of glaucoma. These advancements highlight AI’s pivotal role in enhancing clinical outcomes and operational efficiencies within ophthalmology practices. Patient testimonials further illustrate the tangible benefits of AI in glaucoma care. Patients reported quicker access to diagnostic results and earlier interventions, leading to better eye health management and preserving their vision over time.

These success stories demonstrate AI’s current successes in glaucoma screening and paint a promising picture of its future potential. AI offers a unique blend of accuracy, efficiency, and scalability that traditional methods struggle to match. For more detailed insights into these studies and their methodologies, you can refer directly to Optain Health’s publications, access the full article on glaucoma detection or read more on AI and optical health.

Future Trends in AI for Ophthalmology

The future of AI in ophthalmology is promising, with ongoing research focused on integrating AI with portable and telemedicine platforms. These advancements aim to make glaucoma screening more accessible, especially in remote and underserved areas. Emerging technologies may also enhance AI’s diagnostic capabilities, enabling it to detect a broader range of eye diseases with even greater precision.

Some trends that we’re seeing coming with AI and ophthalmology include:

• Integration with Telemedicine Platforms: AI technologies are increasingly being integrated with telemedicine platforms to enhance remote screening, diagnosis and monitoring of eye conditions. This trend aims to improve accessibility to specialised eye care, especially in underserved areas. Read more about the integration of AI into telehealth platforms.
• Advancements in Wearable Devices: Researchers are developing AI algorithms that can be integrated into wearable devices, such as smart glasses or contact lenses. These devices can continuously monitor eye health metrics and provide patients and healthcare providers with real-time feedback. Read more about the advancement of wearables and AI.

Follow Optain Health to stay updated on the latest advancements in AI for eye care. Learn how these innovations are making glaucoma screenings more accessible worldwide.

FAQs

How does AI improve the accuracy of glaucoma screening? 

AI improves accuracy by analysing large datasets to identify subtle signs of glaucoma that may be missed by traditional methods.

What are the benefits of using AI in eye health checkups? 

Benefits include faster results, higher diagnostic accuracy, and cost savings due to reduced need for specialised equipment and personnel.

Can AI replace doctors in diagnosing glaucoma? 

While AI aids in early detection and screening, it complements rather than replaces doctors. Human expertise is essential for confirming diagnoses and determining treatment plans.

How accessible are AI technologies for glaucoma screening worldwide? 

AI technologies are increasingly accessible, and ongoing efforts are being made to integrate them into telemedicine platforms and portable devices, making screenings available in remote areas.

What future advancements are expected in AI for eye care? 

Future advancements include improved early detection, integration with wearable devices, and expanded capabilities to detect various eye diseases.

For more information, visit Optain Health, learn about our Eyetelligence Assure Suite, and learn about us. If you have any questions, feel free to Contact us.

Understanding Diabetic Retinopathy: The Growing Health Crisis

Diabetic retinopathy is the leading cause of blindness among working-age adults, affecting millions worldwide. It develops when high glucose levels in the blood damage the delicate microvasculature in the retina, the layer of tissue at the back of the eye that senses light and sends images to the brain. The early stages of diabetic retinopathy symptoms may cause mild vision problems, but as the condition progresses, it can result in significant visual impairment.

The Role of Artificial Intelligence in Healthcare: A Paradigm Shift

The integration of Artificial Intelligence (AI) in healthcare marks a transformative shift, particularly in chronic disease management, including diabetes. AI’s capability to analyse large volumes of data with precision and speed offers a revolutionary approach to medical diagnostics and patient care. In diabetes management, AI technologies not only streamline workflow for healthcare providers but also enhance accuracy in early detection and intervention strategies, thereby improving patient outcomes.

Optain Health’s AI Solution: Innovative Tools to Combat Diabetic Retinopathy

At the forefront of AI-driven healthcare solutions is Optain Health, whose pioneering AI-enabled retinal image screening technology, Eyetelligence Assure, allows for the detection of diabetic retinopathy, glaucoma, and neovascular age-related macular degeneration, as well as screening for cardiovascular disease risk factors. 

Eyetelligence Assure, uses clinically validated AI algorithms to non-invasively analyse digital images of the retina, detecting subtle signs of disease early in its course. With an impressive 95% accuracy rate, this technology facilitates early and accurate diagnosis, allowing for timely and effective medical interventions.

Enhanced Patient Diagnostics with the Resolve Camera

The Resolve Camera is a state-of-the-art portable automatic fundus camera crafted for precise health assessments. Engineered with innovative auto-detection capabilities, it ensures accurate retinal imaging by automatically adjusting focus and alignment, significantly reducing the margin for error. Its compact and lightweight design, 16G internal memory, and up to four hours of battery life make it ideal for clinical use.

The Resolve Camera’s advanced voice-command feature guides patients through the imaging process, providing a user-friendly experience that demands minimal operator intervention, while its sophisticated cloud connectivity facilitates efficient data storage, access, and sharing, bolstering collaboration among healthcare professionals. The Resolve Camera is classified as a Class 1 medical device, qualified to performance and safety standards in over thirty countries across the EU and Australasia. 

Benefits of Early Detection: Empowering Healthcare Providers and Patients

The ability to detect diabetic retinopathy at its nascent stage is arguably the most significant advantage of AI in diabetes care. Early detection empowers healthcare providers to implement preventative measures immediately, greatly reducing the risk of progression to severe stages. 

For patients, it means preserving vision and maintaining a better quality of life. The use of AI technologies like Eyetelligence Assure also brings efficiency and scalability to healthcare settings, enabling providers to manage a larger patient base more effectively.

Shaping the Future of Diabetes Care: The Promise and Potential of AI

The integration of AI into diabetes care is reshaping the future of how this chronic condition is managed across the globe. With AI, clinicians are better equipped to make informed decisions quickly, backed by data-driven insights. This shift not only improves the precision of diagnostics and treatments but also holds the promise of making healthcare more accessible and equitable, particularly in regions where resources are scarce.

Looking Into The Future

Artificial Intelligence is transforming the landscape of diabetes care by enhancing the detection and management of diabetic retinopathy and helping to prevent negative outcomes. 

Optain Health’s innovative AI tools epitomise the advancement in medical technology, providing robust, scalable, and efficient solutions that empower healthcare providers and improve patient outcomes in diabetes care. Contact us to learn more.

Frequently Asked Questions

How can I protect my eyes from diabetic retinopathy?

The most effective way to protect your eyes from diabetic retinopathy is to manage your diabetes well. This includes maintaining optimal blood sugar, blood pressure, and cholesterol levels. Regular eye exams are crucial, as they allow for the early detection of any retinal changes, enabling timely intervention. 

How can you reduce diabetic retinopathy naturally?

Reducing the risk of diabetic retinopathy naturally involves comprehensive diabetes management, including diet, exercise, and medication adherence. Lifestyle modifications such as maintaining a healthy diet, engaging in regular physical activity, and avoiding smoking can all contribute to better overall health and a reduced risk of retinopathy. 

Can you reverse diabetic retinopathy?

Reversing established diabetic retinopathy is challenging; however, stabilising and potentially improving vision is possible with early detection and appropriate treatment. Managing diabetes effectively and utilising AI-based screening technologies can help slow or stop the progression of the disease.

Optain Health is at the forefront of these developments, using AI to help improve the accuracy and efficiency of AMD diagnosis and treatment.

Understanding AMD: A Growing Concern in Ageing Populations

AMD is a chronic eye disorder that affects the macula, which is responsible for central vision. This condition can cause severe vision impairment and possibly blindness, making daily tasks such as reading, driving, and recognising people more difficult. There are two forms of AMD: moist and dry. Dry AMD is more common and advances slowly, whereas moist AMD is less common but more severe, frequently resulting in fast vision loss.

As populations age, the prevalence of AMD rises. This emerging health concern emphasises the importance of appropriate diagnostic and therapeutic options for managing and reducing the impact of AMD on patients’ lives.

The Role of AI in Diagnosing and Managing AMD

Artificial intelligence is transforming healthcare, especially in the field of ophthalmology. AI systems can examine massive volumes of data with incredible speed and precision, detecting patterns and abnormalities that the human eye would miss. In the case of AMD, AI can  considerably help improve the diagnosis procedure. 

AI-powered techniques can analyse retinal pictures to detect early indications of AMD with high accuracy. This enables timely intervention and more tailored treatment strategies. In addition, AI can continuously monitor sickness progression, allowing healthcare providers to change treatments as necessary and enhance patient outcomes.

Optain Health’s Pioneering AI Solutions for AMD

Optain Health’s groundbreaking Eyetelligence Assure software suite as a Medical Device (SaMD) uses clinically certified AI algorithms to screen digital retinal pictures. This new technique is ideally positioned to detect early warning signs of neovascular age-related macular degeneration (nAMD), glaucoma, diabetic retinopathy (DR), and cardiovascular disease (CVD). 

Eyetelligence Assure, which has been trained on over 1,000,000 retinal pictures, delivers an outstanding 95% accuracy rate, setting new standards for cost-effective illness detection. Its evidence-based reporting enables physicians to make informed decisions quickly, accurately, and confidently, increasing the efficiency and efficacy of patient care.

Real Life Impact of AI on AMD Treatment

AI’s impact on AMD treatment is significant and well-documented. For example, at Moorfields Eye Hospital in London, AI technology is used to examine retinal images for indicators of AMD and other retinal illnesses. The hospital revealed that AI algorithms could identify AMD as accurately as world-class professionals, dramatically improving diagnostic skills.

Cases like this are becoming more common as AI technology is integrated into clinical practice. AI not only improves diagnostic accuracy but also enables healthcare providers to create more effective, personalised treatment regimens, resulting in better outcomes and greater patient satisfaction.

The Future of Eye Care: Innovations on the Horizon

The future of eye care looks bright, with ongoing advances in AI technology promising even greater breakthroughs in AMD diagnosis and therapy. We are committed to being on the cutting edge of these breakthroughs, ensuring that our AI solutions remain the most powerful and effective tools available. 

We have been looking at innovative AI applications that can help improve diagnostic accuracy, predict disease progression, and adapt treatments to each patient’s specific needs. These technologies will not only benefit AMD patients but will also improve general eye care, establishing new benchmarks for healthcare quality.

Shaping the Future of AMD Care with Optain Health

Optain Health is dedicated to improving eye care with breakthrough AI technologies. Our innovative technology not only improves AMD diagnosis and management but also establishes new standards for healthcare excellence. Optain Health prides itself on enhancing patients’ lives and assisting healthcare providers in providing the best possible treatment by always pushing the boundaries of what AI can accomplish. Contact Optain Health today to find out how our AI solutions can help you or your loved ones.

Frequently Asked Questions

What stands as the most significant healthcare innovation?

Among the foremost healthcare innovations lies the integration of artificial intelligence (AI) into diagnostic and treatment procedures. AI’s capacity to swiftly and accurately analyse vast datasets transforms disease detection and management, elevating patient outcomes and operational efficiency.

What ensures the success of health innovations?

Successful health innovations typically combine advanced technology, rigorous clinical validation, and a focus on enhancing patient outcomes. Collaboration among healthcare providers, researchers, and technology developers is also vital to ensure that innovations are pragmatic and advantageous in real-world scenarios.

Which technology has the most significant impact on healthcare?

Artificial intelligence (AI) has the most profound impact on healthcare today. Its applications in diagnostics, treatment planning, and patient monitoring are revolutionising the industry, leading to more accurate diagnoses, personalised treatments, and superior overall patient care.

The Importance of Early Disease Detection in Healthcare

Early detection of diseases plays a crucial role in improving healthcare outcomes and reducing mortality rates. Conditions identified at an early stage can often be treated more effectively, with less invasive interventions, and at a lower cost. In diseases like cancer, early detection can mean the difference between a treatable illness and a terminal prognosis.In chronic diseases such as diabetes and glaucoma, early intervention can prevent complications and improve the quality of life for patients.

Revolutionising Retinal Image Screening with AI Technology

AI technology enhances the capabilities of retinal imaging significantly. Traditional methods rely heavily on the expertise of clinicians, which can vary widely. AI algorithms, however, can consistently analyse retinal images for signs of diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration with high precision. These algorithms are trained on vast datasets of retinal scans, allowing them to recognise patterns and anomalies that might be missed by the human eye.

Optain Health’s AI Solutions: Advancing Retinal Screening

Optain Health is at the forefront of this revolution with Eyetelligence Assure Suite, a sophisticated Software as a Medical Device (SaMD) system that employs clinically validated AI algorithms to analyse digital retinal images with exceptional accuracy. Trained on over 1,000,000 retinal images, Eyetelligence Assure is adept at detecting early signs of various retinal diseases, including diabetic retinopathy, glaucoma, and age-related macular degeneration.

Eyetelligence Assures cutting-edge capabilities allow for rapid and precise assessments, facilitating early intervention that can significantly alter the course of these diseases. Eyetelligence Assure not only increases the reliability of diagnoses but also enhances the efficiency of the screening process, making high-quality eye care more accessible to patients worldwide.

The Resolve Camera

The Resolve Camera represents an enormous breakthrough in portable automatic fundus camera technology. It boasts state-of-the-art auto-detection features that precisely adjust focus and alignment for accurate retinal imaging, minimising errors and giving the best possible photo. Compact, lightweight, and equipped with a 16G internal memory and up to four hours of battery life, it is ideally suited for dynamic clinical environments.

Featuring advanced voice-command functionality, the Resolve Camera simplifies the imaging process, allowing for a seamless and user-friendly experience with minimal need for operator intervention. Its robust cloud connectivity enhances data storage, access, and sharing capabilities, improving collaboration among healthcare providers. As a Class 1 Medical Device, the Resolve Camera meets stringent performance and safety standards, making it a trusted tool in over thirty countries throughout the EU and Australasia.

The Future of Healthcare: AI’s Expanding Role in Early Detection

The role of AI in healthcare is expanding beyond imaging and diagnostics. AI systems are increasingly being integrated into patient monitoring, treatment plans, and management systems, providing a comprehensive approach to healthcare that is predictive, personalised, and preventative. As AI technology continues to evolve, its potential to transform various aspects of healthcare, including patient engagement and chronic disease management, becomes increasingly apparent.

A New Standard of Care

AI’s revolutionary impact on healthcare, such as through advanced retinal imaging, represents a major leap forward in our ability to diagnose and treat diseases early. Optain Health’s pioneering AI solutions exemplify the powerful role that technology can play in enhancing diagnostic accuracy and improving patient outcomes, setting a new standard in healthcare excellence.

Contact us today to learn more about how AI and retinal imaging can revolutionise your care.

Frequently Asked Questions

How is AI used in the early detection of disease?

AI is used in the early detection of disease by employing machine learning algorithms to analyse medical images, genetic information, or patient data to identify patterns indicative of early-stage diseases. In retinal imaging, AI algorithms analyse images to detect anomalies such as microaneurysms in diabetic retinopathy or optic nerve changes in glaucoma.

What is the application of artificial intelligence in targeting retinal diseases?

AI’s application in targeting retinal diseases involves analysing detailed images of the retina to detect early signs of diseases like diabetic retinopathy, glaucoma, and age-related macular degeneration. These AI systems provide a rapid, accurate assessment of retinal health, allowing for early intervention and better management of these conditions.

How AI in medical imaging may make the biggest impact in healthcare?

AI in medical imaging can make a significant impact in healthcare by improving [we need to make it clear that we facilitate that ‘improvement’ via AI screening] the accuracy and efficiency of diagnoses, reducing the workload on healthcare professionals, and enhancing patient outcomes through earlier detection and personalised treatment plans. AI-driven tools enable more precise measurements, better monitoring of disease progression, and more informed treatment decisions, potentially transforming healthcare into a more proactive, preventive service.

Optain Named to the New York Digital Health 100 by Digital Health New York (DHNY)

DH100 recognizes the most exciting and innovative digital health startups in New York.

New York, NY (February 6, 2024) – Optain today announced that it has been named to the 2024 New York Digital Health 100 (DH100), a recognition that highlights the most exciting and innovative startups in New York. Digital Health New York (DHNY) publishes the annual list in conjunction with the New York Healthcare Innovation Report which takes an in-depth look at the investment trends, opportunities and challenges in the digital health sector.

“Our team at Optain is tirelessly engaged in creating and deploying novel technologies that uniquely improve patient care. We are honored to be recognized in the 2024 New York Digital Health 100. This is a testament to the dedication of our New York, Melbourne, and globally-based team, and reinforces our commitment to democratizing access to care via our revolutionary oculomics and AI platform. We are excited to continue to push the boundaries of digital health innovation and contribute to the advancement of healthcare in New York and across the globe.”said Optain CEO Jeff Dunkel reacting to the DH100 listing.

New York-based healthtech company creation platform Ascertain is investing US$12 (A$18) million in Eyetelligence, a Melbourne-based healthtech company which uses advanced artificial intelligence (AI) technology and retinal imaging to screen for eye and systemic diseases. The technology is based on the inventions of Dr. Mingguang He, a leading clinician-scientist at the University of Melbourne and the Centre for Eye Research Australia who was joined by commercial healthcare leader Jason Sun to found Eyetelligence and now Optain.

Eyetelligence has developed a suite of clinically validated and regulatory approved AI-enabled products already being commercialised in the Australian, New Zealand, European, and Japanese markets. Eyetelligence’s products are used by the Bupa Optical and George & Matilda optometry chains in Australia.

“The three most common eye diseases – diabetic retinopathy, age-related macular degeneration and glaucoma – can be detected far earlier with algorithmic retinal image analysis. These three diseases, however, are just the tip of the iceberg,” said Prof. Mingguang He. “The eye is a window through which we can discern any disease that affects the microvascular system. This technology allows clinicians to act faster and prevent significant impacts on quality of life.”

“I welcome the support of Ascertain who sees the potential of Eyetelligence’s technology for the US and is committed to identifying and accelerating the use of emerging AI technologies to drive significant health benefits globally,” said Professor He, Co-Founder of Eyetelligence.
Eyetelligence is the first international investment by Ascertain, a first of its kind partnership between Aegis Ventures, a next-generation healthcare-focused venture studio, and Northwell Health, one of the largest health systems in the US. Ascertain is committed to accelerating the development of healthcare AI companies globally with a specific eye on Australia.

“Australia has a successful track record of health and biomedical innovations that have been scaled up internationally. Our world-class universities, highly skilled talent and complementary regulatory environment make our healthtech ecosystem a global leader,” said Daniel Boyer, Deputy CEO at the Australian Trade and Investment Commission (Austrade). “Ascertain’s investment in Eyetelligence is a nod to Australia’s cutting-edge biotech sector and shows we are increasingly a partner of choice for US investors.”

Eyetelligence will be rebranded and launched in the US as Optain and aims to enable non-invasive point-of-care technology to diagnose a range of diseases more rapidly, cost-effectively, and accessibly. By enabling earlier diagnosis and treatment, the technology can drive better patient outcomes and cost savings across health systems.

“The healthcare industry has made a concerted effort in recent years to shift treatment from reactive sick-care to proactive preventive care, but many of the legacy screening and diagnostic technologies used by clinicians today are expensive and inaccessible,” said Jeff Dunkel, CEO of Optain. “Optain will accelerate that shift and make preventive care ubiquitous by placing smarter, faster, and more efficient diagnostic tools in the hands of clinicians everywhere.”

“The most immediate opportunity for impact is within ophthalmology,” Dunkel adds. “Optain’s first goal is to expand access to screenings and diagnosis for preventable eye disease, closing critical health equity aps, particularly in underserved communities where diagnostic and screening tools aren’t available.” The Ascertain collaboration will accelerate the availability of Optain’s world-leading Australian
technology in American markets. Eyetelligence will continue to expand under its current brand in Australia and other international markets.

Augmenting the role of traditional venture capital, Ascertain is identifying innovative global healthtech startups and providing them access to world-leading medical, technology, data, and business resources. In doing so, Ascertain has created a first-of-its-kind company creation platform that provides emerging startups access to major early commercialisation partners, regulatory and go-to-market expertise, valuable health data and institutional capital. Together, Ascertain and its portfolio of companies are transforming the model for innovation and entrepreneurship in healthcare to address some of global healthcare’s most challenging problems.